Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Drug Hypersensitivity | 23 | 2021 | 401 | 9.38 | Why? |
| Penicillins | 14 | 2019 | 132 | 7.64 | Why? |
| Anaphylaxis | 9 | 2021 | 940 | 2.50 | Why? |
| beta-Lactams | 4 | 2019 | 210 | 1.53 | Why? |
| Skin Tests | 9 | 2021 | 229 | 1.38 | Why? |
| Anti-Bacterial Agents | 8 | 2019 | 10083 | 1.25 | Why? |
| Allergens | 5 | 2019 | 728 | 1.13 | Why? |
| Surgical Wound Infection | 2 | 2018 | 501 | 0.97 | Why? |
| Drug Eruptions | 3 | 2021 | 319 | 0.92 | Why? |
| Hypersensitivity | 2 | 2021 | 1137 | 0.84 | Why? |
| Electronics, Medical | 1 | 2019 | 4 | 0.82 | Why? |
| Contraindications, Drug | 1 | 2021 | 281 | 0.80 | Why? |
| Electronic Health Records | 6 | 2019 | 3492 | 0.77 | Why? |
| Allergy and Immunology | 2 | 2019 | 240 | 0.74 | Why? |
| Cephalosporins | 2 | 2017 | 250 | 0.72 | Why? |
| Desensitization, Immunologic | 2 | 2021 | 574 | 0.72 | Why? |
| Immunologic Tests | 1 | 2019 | 445 | 0.61 | Why? |
| Physicians, Women | 1 | 2019 | 221 | 0.59 | Why? |
| Antibiotic Prophylaxis | 1 | 2018 | 399 | 0.56 | Why? |
| Decision Support Systems, Clinical | 1 | 2019 | 551 | 0.52 | Why? |
| Faculty, Medical | 1 | 2019 | 595 | 0.49 | Why? |
| Costs and Cost Analysis | 1 | 2017 | 694 | 0.49 | Why? |
| Boston | 3 | 2021 | 929 | 0.47 | Why? |
| Schools, Medical | 1 | 2019 | 793 | 0.45 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 711 | 0.45 | Why? |
| Drug Utilization | 1 | 2017 | 619 | 0.45 | Why? |
| Inpatients | 4 | 2020 | 5161 | 0.44 | Why? |
| Vaccines, Synthetic | 2 | 2021 | 3231 | 0.44 | Why? |
| Clostridium Infections | 1 | 2018 | 595 | 0.43 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 2 | 2018 | 1261 | 0.41 | Why? |
| RNA, Messenger | 7 | 2021 | 5131 | 0.38 | Why? |
| Staphylococcal Infections | 1 | 2018 | 1099 | 0.37 | Why? |
| Amoxicillin | 2 | 2019 | 98 | 0.35 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2017 | 1454 | 0.34 | Why? |
| Data Collection | 1 | 2017 | 1769 | 0.33 | Why? |
| Diagnostic Tests, Routine | 1 | 2017 | 2643 | 0.30 | Why? |
| Documentation | 2 | 2019 | 332 | 0.29 | Why? |
| Immunoglobulin E | 2 | 2019 | 557 | 0.28 | Why? |
| Referral and Consultation | 1 | 2019 | 4816 | 0.25 | Why? |
| Cohort Studies | 8 | 2021 | 36005 | 0.24 | Why? |
| Vaccines | 1 | 2021 | 3692 | 0.24 | Why? |
| Population Surveillance | 1 | 2019 | 4967 | 0.24 | Why? |
| Humans | 41 | 2021 | 930598 | 0.23 | Why? |
| Asthma | 1 | 2020 | 4383 | 0.23 | Why? |
| Skin Pigmentation | 1 | 2021 | 98 | 0.21 | Why? |
| Decision Support Techniques | 2 | 2017 | 903 | 0.20 | Why? |
| Viral Vaccines | 1 | 2021 | 7560 | 0.19 | Why? |
| Vocabulary, Controlled | 1 | 2018 | 26 | 0.18 | Why? |
| Practice Guidelines as Topic | 3 | 2019 | 15421 | 0.18 | Why? |
| Allopurinol | 1 | 2018 | 59 | 0.18 | Why? |
| Incidence | 5 | 2021 | 25622 | 0.18 | Why? |
| Vascular Grafting | 1 | 2017 | 23 | 0.18 | Why? |
| Clindamycin | 1 | 2018 | 59 | 0.18 | Why? |
| Gout Suppressants | 1 | 2018 | 54 | 0.17 | Why? |
| Nausea | 1 | 2021 | 457 | 0.17 | Why? |
| Hypotension | 1 | 2021 | 392 | 0.17 | Why? |
| Risk | 3 | 2019 | 5288 | 0.17 | Why? |
| Community Health Planning | 1 | 2018 | 164 | 0.17 | Why? |
| Clinical Trials, Phase III as Topic | 1 | 2020 | 782 | 0.16 | Why? |
| Adverse Drug Reaction Reporting Systems | 1 | 2021 | 694 | 0.16 | Why? |
| Polyethylene Glycols | 1 | 2021 | 574 | 0.15 | Why? |
| Female | 18 | 2021 | 380317 | 0.15 | Why? |
| Hospitals, General | 1 | 2021 | 711 | 0.15 | Why? |
| Angioedema | 1 | 2017 | 111 | 0.15 | Why? |
| Male | 16 | 2021 | 367725 | 0.14 | Why? |
| Outpatients | 2 | 2019 | 3417 | 0.14 | Why? |
| Vancomycin | 1 | 2018 | 328 | 0.14 | Why? |
| Amputation | 1 | 2017 | 331 | 0.14 | Why? |
| Drug Resistance, Microbial | 1 | 2018 | 419 | 0.14 | Why? |
| Middle Aged | 13 | 2021 | 270681 | 0.13 | Why? |
| United States Food and Drug Administration | 1 | 2020 | 1276 | 0.13 | Why? |
| Massachusetts | 1 | 2018 | 1279 | 0.12 | Why? |
| Arthroplasty, Replacement, Knee | 1 | 2018 | 363 | 0.12 | Why? |
| Arthroplasty, Replacement, Hip | 1 | 2018 | 403 | 0.12 | Why? |
| beta-Lactamases | 1 | 2018 | 759 | 0.12 | Why? |
| Adult | 10 | 2021 | 244371 | 0.12 | Why? |
| Patient Acuity | 1 | 2019 | 1755 | 0.11 | Why? |
| Risk Factors | 6 | 2020 | 71621 | 0.11 | Why? |
| Peripheral Arterial Disease | 1 | 2017 | 471 | 0.11 | Why? |
| Cardiovascular Agents | 1 | 2017 | 663 | 0.11 | Why? |
| Patient Education as Topic | 1 | 2021 | 1476 | 0.11 | Why? |
| Aged | 8 | 2021 | 215776 | 0.11 | Why? |
| United States | 6 | 2020 | 46150 | 0.10 | Why? |
| Standard of Care | 1 | 2017 | 1297 | 0.10 | Why? |
| Ischemia | 1 | 2017 | 901 | 0.09 | Why? |
| United Kingdom | 2 | 2021 | 18046 | 0.09 | Why? |
| African Americans | 2 | 2021 | 3363 | 0.09 | Why? |
| Telemedicine | 1 | 2019 | 25032 | 0.09 | Why? |
| Personnel, Hospital | 1 | 2021 | 2273 | 0.08 | Why? |
| Endovascular Procedures | 1 | 2017 | 1302 | 0.08 | Why? |
| Vaccination | 3 | 2021 | 19050 | 0.08 | Why? |
| Exanthema | 1 | 2017 | 1097 | 0.08 | Why? |
| Patient Selection | 1 | 2021 | 4560 | 0.08 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.08 | Why? |
| Cross Infection | 2 | 2018 | 8675 | 0.08 | Why? |
| Cross Reactions | 1 | 2017 | 4374 | 0.08 | Why? |
| Odds Ratio | 1 | 2018 | 5861 | 0.08 | Why? |
| Aged, 80 and over | 4 | 2020 | 88759 | 0.07 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.07 | Why? |
| Clinical Decision-Making | 1 | 2017 | 3755 | 0.06 | Why? |
| Consensus | 1 | 2017 | 6345 | 0.06 | Why? |
| Mortality | 1 | 2019 | 7132 | 0.06 | Why? |
| Computer Simulation | 1 | 2017 | 4982 | 0.06 | Why? |
| Gastrointestinal Diseases | 1 | 2017 | 2580 | 0.06 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.05 | Why? |
| Excipients | 1 | 2021 | 118 | 0.05 | Why? |
| Ambulatory Care | 1 | 2017 | 4947 | 0.05 | Why? |
| Systematized Nomenclature of Medicine | 1 | 2018 | 30 | 0.05 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2017 | 5277 | 0.05 | Why? |
| Global Health | 2 | 2021 | 13911 | 0.05 | Why? |
| Hypersensitivity, Delayed | 1 | 2018 | 81 | 0.04 | Why? |
| Retreatment | 1 | 2017 | 186 | 0.04 | Why? |
| Hypersensitivity, Immediate | 1 | 2018 | 134 | 0.04 | Why? |
| Pregnancy | 1 | 2019 | 23879 | 0.04 | Why? |
| Infant | 1 | 2019 | 30274 | 0.04 | Why? |
| Decision Trees | 1 | 2017 | 441 | 0.04 | Why? |
| Markov Chains | 1 | 2017 | 502 | 0.04 | Why? |
| Child, Preschool | 1 | 2019 | 36283 | 0.04 | Why? |
| Quality-Adjusted Life Years | 1 | 2017 | 511 | 0.03 | Why? |
| Asian Americans | 1 | 2018 | 387 | 0.03 | Why? |
| Natural Language Processing | 1 | 2018 | 436 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.03 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.03 | Why? |
| Cross-Sectional Studies | 1 | 2019 | 53120 | 0.03 | Why? |
| Adolescent | 2 | 2019 | 86841 | 0.03 | Why? |
| Datasets as Topic | 1 | 2018 | 1404 | 0.03 | Why? |
| Young Adult | 2 | 2019 | 93724 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2017 | 15909 | 0.03 | Why? |
| Stents | 1 | 2017 | 916 | 0.02 | Why? |
| Child | 1 | 2019 | 70012 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.02 | Why? |
| Databases, Factual | 1 | 2018 | 6248 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.01 | Why? |
| Socioeconomic Factors | 1 | 2018 | 8495 | 0.01 | Why? |
| Registries | 1 | 2021 | 12327 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.01 | Why? |
| Critical Illness | 1 | 2017 | 17281 | 0.01 | Why? |
| Risk Assessment | 1 | 2017 | 25439 | 0.01 | Why? |
| Comorbidity | 1 | 2017 | 34796 | 0.01 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.01 | Why? |
Blumenthal's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(142)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(62)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_